Xylitol only chewing gum
ApprovedSmall molecule
Xylitol only chewing gum is one of 21 small molecule programs targeting Gingivitis. It is currently in Approved.
1
Indications
1
Total Trials
0
Active Trials
20
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
45 competitors in Gingivitis
#DrugCompanyPhaseTrials
1Flagyl
DDePuy Orthopaedics
Approved
Peridex
DDexcel Pharma Technologies Ltd.
Approved
Cetylpyridinium Chloride
SanofiApproved
Tea Tree Oil
FFederal University of São Paulo
Approved
Triclosan
CColgate Palmolive
Phase 3
Active Comparator
ModernaPhase 2
Xylitol only chewing gum
TThe University of Texas Health Science Center, Houston
Approved
Negative Control
GSKPhase 3
Test
RRespirent Pharmaceuticals Co Ltd.
Phase 2
Sodium Laural Sulfate
GSKPhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Xylitol only chewing gum. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details